Biotechnology Companies By Pe Ratio

Price To Earning
Price To EarningEfficiencyMarket RiskExp Return
1AMRN Amarin PLC
590.0
 0.17 
 6.50 
 1.11 
2ARWR Arrowhead Pharmaceuticals
482.39
 0.18 
 4.15 
 0.73 
3EVO Evotec SE ADR
444.0
(0.12)
 3.27 
(0.39)
4ENTA Enanta Pharmaceuticals
366.13
 0.20 
 3.75 
 0.75 
5GILD Gilead Sciences
359.42
(0.03)
 1.82 
(0.05)
6VCEL Vericel Corp Ord
357.33
 0.18 
 2.91 
 0.53 
7URGN UroGen Pharma
239.57
 0.17 
 3.83 
 0.64 
8BMRN Biomarin Pharmaceutical
220.73
(0.02)
 1.53 
(0.04)
9PSTX Poseida Therapeutics
214.0
 0.13 
 5.29 
 0.69 
10NBIX Neurocrine Biosciences
202.9
 0.16 
 1.57 
 0.25 
11ICCC ImmuCell
195.0
 0.10 
 2.28 
 0.23 
12XRTX XORTX Therapeutics
170.67
 0.06 
 6.87 
 0.42 
13SNDX Syndax Pharmaceuticals
126.11
 0.22 
 3.16 
 0.69 
14ARCT Arcturus Therapeutics Holdings
119.5
 0.22 
 4.30 
 0.95 
15SILO Silo Pharma
118.39
 0.02 
 3.94 
 0.08 
16IONS Ionis Pharmaceuticals
101.16
(0.02)
 2.21 
(0.05)
17FGEN FibroGen
97.67
 0.22 
 14.27 
 3.10 
18CLGN Collplant Biotechnologies
92.6
 0.02 
 4.11 
 0.07 
19CSTL Castle Biosciences
87.86
 0.13 
 3.36 
 0.43 
20IPSC Century Therapeutics
86.08
 0.26 
 7.43 
 1.92 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit. Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.